Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results
August 7, 2026
Biotechnology
-
-
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
August 7, 2026
-
Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 7, 2026
-
Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update
August 7, 2026
-
Kane Biotech Announces Engagement of DNA Advisors
August 5, 2026
-
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
August 5, 2026
-
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
August 4, 2026
-
Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company
August 3, 2026
-
Compugen Reports Second Quarter 2026 Results
August 3, 2026
-
Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome
August 3, 2026
-
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
August 3, 2026
-
Cerenome Launches as an Integrated CNS Oncology Company
July 31, 2026
-
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
July 31, 2026
-
SciSparc: Subsidiary NeuroThera Labs’ Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics
July 31, 2026
-
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
July 31, 2026
-
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
July 31, 2026